Augmented Reality for Orthognatic Surgery Patient Education (NARRATE)

March 12, 2024 updated by: University Medical Center Groningen
To evaluate whether the use of augmented reality (AR) for visualizing 3D models can be a valuable addition to patient education regarding orthognathic procedures compared to using only 2D visualization (on a computer screen).

Study Overview

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Phase 2
  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Aachen, Germany
        • Recruiting
        • Uniklinik RWTH Aachen
        • Contact:
        • Sub-Investigator:
          • Ashkan Rashad
        • Sub-Investigator:
          • Oliver-Costin Vladu
      • Groningen, Netherlands
      • Utrecht, Netherlands

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients planned for an orthognathic intake consult in the period of July to april 2024 at the UMCU or UMCG or Uniklinik RTWH Aachen;
  • Patients with dentofacial deformity (dysgnathia) including: class II malocclusion, class III malocclusion, or open bite;
  • Patients undergoing treatment using BSSO (Bilateral Sagittal Split Osteotomy), Le Fort I, or BIMAX;
  • The planned treatment is either with or without a genioplasty procedures.
  • Patients 16 years of age or older.

Exclusion Criteria:

  • Patients with craniofacial syndromes, such as cleft lip and palate
  • Patient which require an osteotomy involving two or more segments

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: 2D Monitor screen
Patient consultation with 3D models of bone and skin, seen with a monitor screen
Providing information about the current clinical problem of orthognatic surgery patients and the proposed treatment for it.
Experimental: 3D AR
Patient consultation with 3D models of bone and skin, seen in augmented reality trough AR glasses
Providing information about the current clinical problem of orthognatic surgery patients and the proposed treatment for it.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient satisfaction
Time Frame: Immediately after the regular first intake consult
Patient satisfaction of the intake consult. Focussed on the explanation of the condition and proposed treatment, measured through a questionnaire. The questionnaire measures the clarity and importance of the information for the patient. For both parameters a median score will be calculated between 0 and 5
Immediately after the regular first intake consult
Objective knowledge
Time Frame: Immediately after the regular first intake consult
Patient knowledge of the medical problem and proposed treatment, also measured by a questionnaire. Patient can get 2 points when all four question are right, if all questions are answered incorrectly, then -2 points
Immediately after the regular first intake consult

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diagnosis
Time Frame: During the first intake consult
Orthognatic diagnosis
During the first intake consult
Occlusion Class
Time Frame: During the first intake consult
Class of the occlusion of the patient before surgery
During the first intake consult

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: J Kraeima, dr., UMC Groningen

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2023

Primary Completion (Estimated)

April 30, 2024

Study Completion (Estimated)

June 1, 2024

Study Registration Dates

First Submitted

October 25, 2023

First Submitted That Met QC Criteria

November 16, 2023

First Posted (Actual)

November 18, 2023

Study Record Updates

Last Update Posted (Actual)

March 15, 2024

Last Update Submitted That Met QC Criteria

March 12, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Malocclusion

Clinical Trials on Patient consultation

3
Subscribe